Post-Operative Radiotherapy for Non-Small Cell Lung Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN46536242

Enrollment

308

Registered

2002-08-19

Start date

2002-01-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung (non-small cell) cancer Cancer Malignant neoplasm of bronchus or lung

Interventions

Patients are randomised two to four weeks postoperatively to either: 1. Schedule R: Radiotherapy 40 Gy given in daily fractions five days a week over three weeks to mediastinum startin

Eligibility

Inclusion criteria

Inclusion criteria: 1. Either sex, aged 75 years or less 2. World Health Organisation (WHO) performance status zero to two 3. Lung and cardiac function adequate for proposed resection 4. pT1 pN1 M0, pT2 pN1 M0, pT1 pN2 M0 or pT2 pN2 M0 non-small cell lung cancer 5. Complete resection of non-small cell lung cancer

Exclusion criteria

Exclusion criteria: 1. Previous specific anti-cancer treatment for current disease 2. Presence of other malignant disease, except basal cell carcinoma or in situ carcinoma of the cervix 3. Presence of other serious condition contraindicating surgery or radiotherapy

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration.	—

Secondary

Measure	Time frame
Not provided at time of registration.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026